Preventive Efficacy, Safety, Immunogenic Activity, and Evaluation of Post-Vaccination Responses Following Immunization with Combined Trivalent Vaccine Vaktrivir (Measles-Rubella-Parotitis) in Premature Infants
Background. Registration of combined trivalent vaccine Vaktrivir (measles-rubella-parotitis) in Russia necessitates studies on its preventive efficacy, safety, immunogenic activity, and post-vaccination responses following the immunization of premature infants. Objective. The aim of the study is to...
Saved in:
Main Authors: | Vadislav V. Semerikov, Nina O. Yаkobyuk, Lyudmila V. Sofronova, Nadezhda V. Yuminova, Natalia N. Vorobjeva, Nikolay A. Kontarov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Union of pediatricians of Russia
2024-05-01
|
Series: | Педиатрическая фармакология |
Subjects: | |
Online Access: | https://www.pedpharma.ru/jour/article/view/2435 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Combination Vaccine against Measles
by: M. P. Kostinov
Published: (2020-09-01) -
Domestic Tetravaccine (Measles-Rubella-Mumps) – Immunization of Premature Babies
by: V. V. Semerikov, et al.
Published: (2022-09-01) -
Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir<sup>®</sup> in children 12 months and 6 years of age (results of a simple blind multicenter comparative randomized clinical trial)
by: I. V. Feldblium, et al.
Published: (2021-03-01) -
Herd Immunity to the Measles, Mumps and Rubella Viruses Among the Belgradian Population in May, 2024
by: Anna Y. Popova, et al.
Published: (2025-06-01) -
Characteristics of the epidemic process of measles, rubella and mumps in Moscow and assessment of their seroprevalence at the present stage
by: Yana V. Simakova, et al.
Published: (2025-04-01)